The present invention relates to compounds of formula (I) including any stereochemically isomeric form thereof, or pharmaceutically acceptable salts thereof, for the treatment of tuberculosis.
-
Paragraph 0057
(2017/09/28)
More Articles about upstream products of 5397-75-1